Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

627 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression].
Rubio-Briones J, Calatrava A, Fernández-Serra A, Ramos Ruiz R, Iborra I, García-Casado Z, Rubio L, Trassierra M, Collado A, Casanova J, Gómez-Ferrer A, Solsona E, López-Guerrero JA. Rubio-Briones J, et al. Among authors: rubio l. Actas Urol Esp. 2011 Feb;35(2):80-6. doi: 10.1016/j.acuro.2010.10.003. Epub 2011 Jan 21. Actas Urol Esp. 2011. PMID: 21256634 Spanish.
[Outcomes of expanded use of PCA3 testing in a Spanish population with clinical suspicion of prostate cancer].
Rubio-Briones J, Fernández-Serra A, Ramírez M, Rubio L, Collado A, Casanova J, Gómez-Ferrer A, Ricós JV, Monrós JL, Dumont R, Ortiz B, Iborra I, García-Casado Z, Solsona E, López-Guerrero JA. Rubio-Briones J, et al. Among authors: rubio l. Actas Urol Esp. 2011 Nov-Dec;35(10):589-96. doi: 10.1016/j.acuro.2011.04.001. Epub 2011 Jun 22. Actas Urol Esp. 2011. PMID: 21700365 Spanish.
Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program.
Rubio-Briones J, Casanova J, Dumont R, Rubio L, Fernandez-Serra A, Casanova-Salas I, Domínguez-Escrig J, Ramírez-Backhaus M, Collado A, Gómez-Ferrer A, Iborra I, Monrós JL, Ricós JV, Solsona E, Salas D, Martínez F, Lopez-Guerrero JA. Rubio-Briones J, et al. Among authors: rubio l. Actas Urol Esp. 2014 May;38(4):217-23. doi: 10.1016/j.acuro.2013.09.007. Epub 2013 Oct 27. Actas Urol Esp. 2014. PMID: 24169211 Clinical Trial. English, Spanish.
External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.
Ramírez-Backhaus M, Fernández-Serra A, Rubio-Briones J, Cruz Garcia P, Calatrava A, Garcia Casado Z, Casanova Salas I, Rubio L, Solsona E, López-Guerrero JA. Ramírez-Backhaus M, et al. Among authors: rubio l, rubio briones j. Actas Urol Esp. 2015 Oct;39(8):473-81. doi: 10.1016/j.acuro.2015.02.002. Epub 2015 Apr 25. Actas Urol Esp. 2015. PMID: 25920992 English, Spanish.
PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme.
Rubio-Briones J, Casanova J, Martínez F, Domínguez-Escrig JL, Fernández-Serra A, Dumont R, Ramírez-Backhaus M, Gómez-Ferrer A, Collado A, Rubio L, Molina A, Vanaclocha M, Sala D, Lopez-Guerrero JA. Rubio-Briones J, et al. Among authors: rubio l. Actas Urol Esp. 2017 Jun;41(5):300-308. doi: 10.1016/j.acuro.2016.10.008. Epub 2017 Mar 23. Actas Urol Esp. 2017. PMID: 28342633 Clinical Trial. English, Spanish.
Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.
Casanova-Salas I, Rubio-Briones J, Calatrava A, Mancarella C, Masiá E, Casanova J, Fernández-Serra A, Rubio L, Ramírez-Backhaus M, Armiñán A, Domínguez-Escrig J, Martínez F, García-Casado Z, Scotlandi K, Vicent MJ, López-Guerrero JA. Casanova-Salas I, et al. Among authors: rubio l, rubio briones j. J Urol. 2014 Jul;192(1):252-9. doi: 10.1016/j.juro.2014.01.107. Epub 2014 Feb 8. J Urol. 2014. PMID: 24518785
Clinico-pathological significance of the molecular alterations of the SPOP gene in prostate cancer.
García-Flores M, Casanova-Salas I, Rubio-Briones J, Calatrava A, Domínguez-Escrig J, Rubio L, Ramírez-Backhaus M, Fernández-Serra A, García-Casado Z, López-Guerrero JA. García-Flores M, et al. Among authors: rubio l, rubio briones j. Eur J Cancer. 2014 Nov;50(17):2994-3002. doi: 10.1016/j.ejca.2014.08.009. Epub 2014 Sep 6. Eur J Cancer. 2014. PMID: 25204806
Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.
Rubio-Briones J, Borque A, Esteban LM, Casanova J, Fernandez-Serra A, Rubio L, Casanova-Salas I, Sanz G, Domínguez-Escrig J, Collado A, Gómez-Ferrer A, Iborra I, Ramírez-Backhaus M, Martínez F, Calatrava A, Lopez-Guerrero JA. Rubio-Briones J, et al. Among authors: rubio l. BMC Cancer. 2015 Sep 11;15:633. doi: 10.1186/s12885-015-1623-0. BMC Cancer. 2015. PMID: 26362197 Free PMC article.
627 results